# Emergent BioSolutions Inc.: Form 8-K, filed Oct 2, 2017

- Company: [Emergent BioSolutions Inc.](/companies/ebs.md) (CIK 1367644)
- Form: 8-K
- Filed: 2017-10-02
- Accepted by EDGAR: Oct 2, 2017, 08:03 ET
- Period: 2017-10-02
- Accession: 0001367644-17-000036
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1367644/000136764417000036/form8kpressrelease10022017.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1367644/000136764417000036/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 1.02: Termination of a material agreement
- Item 2.03: New direct financial obligation
- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1367644/000136764417000036/form8kpressrelease10022017.htm

Filed Oct 2, 2017.
Source: SEC EDGAR, the filing index for accession 0001367644-17-000036. Last ingested by Listed: Nov 4, 2026, 16:51 ET. No prices; not investment advice.
